Fischer Medical Ventures Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹107 Cr +24.5% YoYSee revenue, profit and what management said. You are viewing Q1 FY27.
FM

Fischer Medical Ventures Ltd

Q1 FY27Healthcare Equipment & Supplies

Fischer Medical Ventures Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹82Cr
+249.5% YoY
−16% QoQ
Net profit
₹4Cr
−22% YoY
Turned profitable QoQ
Margin
13.73%
−3.3 pp YoY
+17.6 pp QoQ

Based on Fischer Medical Ventures Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹34
Market cap₹2.3K Cr
P/E94.6

Revenue & Sales Performance

See what Fischer Medical Ventures Ltd said on revenue & sales performance — free account, 30 seconds.

Profitability & Margins

See what Fischer Medical Ventures Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

See what Fischer Medical Ventures Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Healthcare Equipment & Supplies

Ranked on what management guided this quarter

Guidance-ranked
1OSEL Devices
Rev 1Mar 3
Rev 1Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Fischer Medical Ventures Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Fischer Medical Ventures Ltd said on order book & pipeline — free account, 30 seconds.

Fischer Medical Ventures Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Fischer Medical Ventures Ltd Q1 FY27 results — key figures

Fischer Medical Ventures Ltd Q1 FY27 reported results vs year-ago quarter, ₹ crore
₹ CrQ1 FY27
Revenue82
Operating profit (EBITDA)11
Operating margin13.7%
Profit before tax8
Net profit (PAT)4
EPS (₹)0.06

Source: Fischer Medical Ventures Ltd's results filing to NSE (consolidated), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹107 Cr, net profit ₹1 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Equipment & Supplies this season

  • Nureca (Q1 FY27)

    Revenue from Operations for Q1 FY'27: ₹40.3 Cr . Key investor presentation takeaways from Nureca's Q1 FY27 investor presentation — and how it ranks against sect

  • Avience Biomedicals (Q1 FY27)

    New manufacturing facility has capacity to support peak revenue of around ₹250–265 crore, subject to product mix and approvals. Key concall takeaways from…

  • Molbio Diagnosti (Q1 FY27)

    Capacity utilization currently at ~58% for test kits and ~42% for devices; automation capex will double revenue capacity with minimal new investment. Key…

  • QMS Medical (Q1 FY27)

    Contract renewals historically exhibit a 60-70% roll-over rate annually, ensuring revenue visibility from existing clients. Key concall takeaways from QMS…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Fischer Medical Ventures Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What is Fischer Medical Ventures Ltd share price analysis?

Fischer Medical Ventures Ltd currently shows a neutral. The stock trades at a P/E of 94.6 with a market cap of ₹2,316 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Fischer Medical Ventures Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.